Shanghai INT Medical Instruments Co., Ltd. (HKG:1501)
Hong Kong · Delayed Price · Currency is HKD 37.80
-1.64 (-4.16%)
May 12, 2026, 4:08 PM HKT
HKG:1501 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 218.79 | 191.91 | 156.46 | 131.71 | 142.96 |
Depreciation & Amortization | 102.45 | 78.54 | 46.63 | 36.41 | 29.69 |
Other Amortization | 1.78 | 1.33 | 0.92 | 0.67 | 0.52 |
Loss (Gain) From Sale of Assets | -0.48 | 0.02 | 0.62 | 0.24 | 0.11 |
Asset Writedown & Restructuring Costs | 0.21 | 0.62 | - | - | 0.57 |
Loss (Gain) From Sale of Investments | -7.15 | 8.03 | -2.08 | -7.36 | -29.29 |
Loss (Gain) on Equity Investments | 0.59 | 0.4 | - | - | - |
Stock-Based Compensation | 8.07 | 6.79 | 6.49 | 3.11 | 1.11 |
Provision & Write-off of Bad Debts | -0.21 | -0.63 | 0.41 | 0.93 | - |
Other Operating Activities | 17.16 | -24.23 | -6.25 | -14.55 | -13.6 |
Change in Accounts Receivable | 12.98 | -16.48 | -44.22 | 7.73 | -74.94 |
Change in Inventory | 1.8 | -35.57 | 21.12 | -62.03 | -37.29 |
Change in Accounts Payable | -14.92 | 26 | 20.18 | 55.67 | 23.22 |
Change in Unearned Revenue | 7.06 | -11.17 | -22.13 | 27.95 | 29.7 |
Operating Cash Flow | 348.11 | 225.54 | 178.15 | 180.46 | 72.76 |
Operating Cash Flow Growth | 54.34% | 26.61% | -1.28% | 148.03% | -23.98% |
Capital Expenditures | -64.48 | -125.74 | -168.84 | -243.21 | -277.83 |
Sale of Property, Plant & Equipment | 1.53 | 3.72 | 0.78 | 0.87 | 1 |
Cash Acquisitions | -300.18 | - | - | - | - |
Sale (Purchase) of Intangibles | -50.13 | -40 | -62.36 | -45 | -25.28 |
Investment in Securities | -148.87 | -34.42 | -64.28 | -35.38 | 19.5 |
Other Investing Activities | 12.1 | 9.13 | 10.89 | 6.52 | 14.53 |
Investing Cash Flow | -550.03 | -187.31 | -283.81 | -316.18 | -268.08 |
Short-Term Debt Issued | 738.79 | 228.02 | 88.34 | 32.66 | - |
Total Debt Issued | 738.79 | 228.02 | 88.34 | 32.66 | - |
Short-Term Debt Repaid | -447.25 | -80 | -42 | - | - |
Long-Term Debt Repaid | -7.04 | - | - | -0.19 | -0.32 |
Total Debt Repaid | -454.29 | -80 | -42 | -0.19 | -0.32 |
Net Debt Issued (Repaid) | 284.51 | 148.02 | 46.34 | 32.47 | -0.32 |
Issuance of Common Stock | - | 60 | 36 | 24 | - |
Repurchase of Common Stock | -3.61 | -18.92 | -21.26 | - | - |
Common Dividends Paid | - | -47.12 | -40.32 | -43.68 | -47.31 |
Other Financing Activities | 36.4 | -85.02 | -12.7 | -3.07 | 16.56 |
Financing Cash Flow | 317.3 | 56.97 | 8.06 | 9.72 | -31.07 |
Foreign Exchange Rate Adjustments | -6.62 | 3.08 | 3.01 | 3.72 | -3.19 |
Net Cash Flow | 108.75 | 98.29 | -94.6 | -122.28 | -229.58 |
Free Cash Flow | 283.63 | 99.8 | 9.31 | -62.75 | -205.07 |
Free Cash Flow Growth | 184.18% | 972.35% | - | - | - |
Free Cash Flow Margin | 26.62% | 11.71% | 1.24% | -10.71% | -44.13% |
Free Cash Flow Per Share | 1.65 | 0.58 | 0.05 | -0.37 | -1.23 |
Cash Interest Paid | 12.32 | 1.54 | 2.35 | 0.15 | 0.07 |
Cash Income Tax Paid | 32.7 | 38.73 | 19.59 | 12.66 | 15.02 |
Levered Free Cash Flow | 195.6 | -29.79 | -63.2 | -169.73 | -228.1 |
Unlevered Free Cash Flow | 203.44 | -28.27 | -61.2 | -169.22 | -227.7 |
Change in Working Capital | 6.91 | -37.22 | -25.06 | 29.31 | -59.32 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.